Glaxosmithkline Pharmaceuticals Limited · NSE:GLAXO
Glaxosmithkline Pharmaceuticals — FY2009 Earnings Presentation
12 slides from Glaxosmithkline Pharmaceuticals's earnings presentation, Feb 18, 2010
Slide 1: Results 2009 Presentation to Analysts
Results 2009 Presentation to Analysts 18th February 2010
Slide 2: Q4 2009 Performance
Q4 2009 Performance Q4 2009 Q 4 2008 Change Rs. Mn Rs. Mn Net Sales 4,444 3,685 20.6% Consumption 1,584 1,482 6.9% 35.6% 40.2% Operating expenses 1,524 1,202 26.8% 34.3% 32.6% PAT before exceptional items 1,067 892 19.6% 24.0% 24.2%
Slide 3: 2009 Performance Summary
2009 Performance Summary 2009 2008 % Change Rs. Mn Rs. Mn Turnover 18,708 16,604 12.7 EPS (in Rs.) 59.61 52.93 12.6 Operating Cashflow 6,957 5,647 23.2 EPS before exceptional items
Slide 4: 2009 Turnover Summary
2009 Turnover Summary 2009 2008 % Change Rs. Mn Rs. Mn Pharmaceuticals 17,144 15,318 12 Iodex 849 694 22 Exports and Beta 716 593 21 Total 18,709 16,604 13
Slide 5: Growth YTD 2009
Growth YTD 2009 In INR Mn Net Sales 18,708 12.7% Gross Margin 11,786 16.4% Staff costs 2,093 21.2% Other Opex 3,309 18.8% Other income 203 Trading Profit 6,587 13.2% Treasury Income 999 2,536 Taxes PAT 5,049 12.6%
Slide 6: New Launches
New Launches 2007-2008 Key …..2009 Launches
Slide 7: Building the right portfolio
Building the right portfolio
Slide 8: 2009 Performance Summary
2009 Performance Summary 2009 2008 Change Rs. Mn Rs. Mn Net Sales 18,708 16,604 12.7% Consumption 6,922 6,476 6.9% 37.0% 39.0% Operating expenses 5,403 4,515 19.7% 28.9% 27.2% Other Income 203 207 Operating Profit 6,586 5,820 13.2% 35.2% 35.1% Treasury Income 999 979 PBT before exceptional items 7,5
Slide 9: Exceptional items
Exceptional items 2009 2008 Rs. Mn Rs. Mn Expenses for rationalisation initiatives (104) - Profit on sale of property 89 - Compensation for surrender of rental premises 13 - Expenses for acquisition of Stiefel distribution rights (71) - Provision for pricing of formulations - (43) Profit on sale / r
Slide 10: Full year results after Exceptional items
Full year results after Exceptional items 2009 2008 % Change Rs. Mn Rs. Mn Profit before exceptional items 5,049 4,484 12.6% Exceptional income 74 1,282 Net Profit 5,123 5,766
Slide 11: Cash Flow
Cash Flow 2009 2008 Rs. Mn Rs. Mn Profit before taxation and exceptional items 7,585 6,799 Depreciation and other non-cash items (850) (819) Increase/(Decrease) in Working Capital 222 (333) Cash generated from operations 6,957 5,647 Taxation (1,774) (2,402) Cash flow before exceptional items 5,183 3
Slide 12: Do more, feel better, live longer
Do more, feel better, live longer
GlaxoSmithKline Pharmaceuticals — FY2009 Earnings Presentation on 6ix